Studying Neuroendocrine Transdifferentiation as a Mechanism of Drug Resistance
Time: 1:30 pm
day: Day Two
- How do mutiple tumors acquire resistance to targeted therapeutics by transdifferentiation?
- Understanding if there is a common epigenetic state in the resulting neuroendocrine tumor type
- Exploring how intratumoral heterogeneity is detected in these tumors